Home › Breast Cancer › Pennsylvania › Hazleton
Breast Cancer clinical trials in Hazleton, PA
4 studies for Breast Cancer are looking for participants at sites in and around Hazleton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- Geisinger Medical Center-Cancer Center Hazleton, Hazleton
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Lehigh Valley Hospital-Hazleton, Hazleton
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Geisinger Medical Center-Cancer Center Hazleton, Hazleton
- Lehigh Valley Hospital-Hazleton, Hazleton
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Lehigh Valley Hospital-Hazleton, Hazleton
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. Learn about the types, diagnosis, and treatments.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY144 studies
- Houston, TX126 studies
- Boston, MA110 studies
- Nashville, TN78 studies
- Los Angeles, CA73 studies
- Edison, NJ70 studies
- Queens, NY67 studies
- Durham, NC63 studies
- St. Louis, MO63 studies
- Chicago, IL59 studies
- Dallas, TX54 studies
- Philadelphia, PA51 studies
Other studies in Hazleton
- Colorectal Cancer5 studies
- Non-Small Cell Lung Cancer4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Prostate Cancer4 studies
- Colon Cancer4 studies
- Cancer (all types)3 studies
- Ovarian Cancer3 studies
- Multiple Myeloma3 studies
- Bladder Cancer3 studies
- Lung Cancer3 studies
- Rectal Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.